类风湿性关节炎的突液诱导了人类感觉神经元的JAK-依赖的细胞内激活
Yuening Li1, Elizabeth H Gray1, Rosie Ross1
1Department of Inflammation Biology, King's College London, London, United Kingdom.
JCI insight
|May 15, 2025
概括
简氏激酶抑制剂 (JAKi) 直接影响感觉神经元,解释了它们在减少类风湿性关节炎疼痛方面的有效性. 这项研究揭示了JAKi.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 简氏激酶抑制剂 (JAKi) 是一种抗炎药物,在类风湿性关节炎 (RA) 中观察到优异的疼痛减轻作用.
- 根据JAKi的止痛作用的确切机制,特别是直接的神经元作用,仍然不清楚.
研究的目的:
- 调查JAK抑制剂 (JAKi) 是否直接影响人类感觉神经元.
- 在类风湿性关节炎 (RA) 的背景下,探索Janus kinase (JAK) 和信号转换器和转录3 (STAT3) 信号的激活器在感觉神经元中的作用.
主要方法:
- 分析人类感官神经元的RNA测序数据,以确定JAK1和STAT3的表达.
- 诱导多能干细胞 (iPSC) 衍生的人类感觉神经元的治疗与类风湿性关节炎 (RA) 结膜液和特定细胞因子.
- 评估STAT3酸化 (pSTAT3) 和基因表达的变化,以应对JAK抑制剂 (如托法西提尼布) 和细胞因子.
- 电生理学记录来测量神经元的发射速度.
主要成果:
- 人类感觉神经元表达JAK1和STAT3.
- 在感觉神经元中,RA结膜液诱导了STAT3酸化 (pSTAT3),这种效应被托法西提尼布阻断.
- RA 突流体显示了 STAT3 信号细胞因子 (IL-6,IL-11,LIF,IFN-alpha,IFN-beta) 的丰富,这些细胞因子也被发现在神经元中诱导 pSTAT3.
- 像IL-6和LIF这样的细胞因子调高了与疼痛相关的基因和LIF诱导的神经元敏感化,tofacitinib抑制了这些效应.
- 托法西替尼 (tofacitinib) 降低了RA突流体刺激的感觉神经元的发射速度.
结论:
- 雅克抑制剂 (JAKi) 直接作用于人类的感觉神经元.
- 感觉神经元中的JAK-STAT3信号由RA突流体成分激活.
- 这种直接的神经元作用为JAKi在类风湿性关节炎 (RA) 中降低疼痛效果提供了一个潜在的机制.
更多相关视频
12:23Flow Cytometry Analysis of Immune Cell Subsets within the Murine Spleen, Bone Marrow, Lymph Nodes and Synovial Tissue in an Osteoarthritis Model
Published on: April 24, 2020
19.3K
11:03A Cryo-pulverization Protocol for Processing Mouse Paws to Evaluate Molecular Pathways of Tissue Inflammation in a Collagen Induced Arthritis Model
Published on: October 30, 2019
8.0K
相关概念视频
The JAK-STAT Signaling Pathway
8.5K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.5K
T Cell Types and Functions
689
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
689
